Early changes in CSF sTREM2 in dominantly inherited Alzheimer’s disease occur after amyloid deposition and neuronal injury
Science Translational Medicine 14 Dec 2016: Vol. 8, Issue 369, pp. 369ra178 DOI: 10.1126/scitranslmed.aag1767
Authors/Editors: |
Marc Suárez-Calvet Miguel Ángel Araque Caballero Gernot Kleinberger Randall J. Bateman Anne M. Fagan John C. Morris Johannes Levin Adrian Danek Michael Ewers Christian Haass for the Dominantly Inherited Alzheimer Network |
---|---|
Publication Date: | 2016 |
Type of Publication: | Journal Article |
Little is known about the role of microglia in Alzheimer’s disease (AD). TREM2 is a protein expressed by microglia. Mutations in TREM2 increase the risk for neurodegenerative diseases including AD. Suárez-Calvet and colleagues have measured the amount of a secreted form of TREM2 (sTREM2) as a surrogate marker for microglial activation. They measured sTREM2 in the cerebrospinal fluid (CSF) of a unique cohort of 127 subjects with autosomal dominant AD and 91 healthy siblings. CSF sTREM2 was abnormally increased 5 years before the expected onset of symptoms in the AD patients. This increase occurred after alterations in markers for brain amyloidosis and neuronal injury.
Related Links
- Science Translational Medicine DOI: 10.1126/scitranslmed.aag1767
- Deutschlandfunk: Protein im Nervenwasser: Forscher finden Frühzeichen für Alzheimer (Interview: Audio)
- Frühzeichen für Alzheimer im Nervenwasser
- Early signs in cerebrospinal fluid
- Münchner Forscher finden im Nervenwasser Frühzeichen für Alzheimer
- Early signs of Alzheimer’s detected in cerebrospinal fluid